methotrexate has been researched along with Diathesis in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.17) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 8 (33.33) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Elsewedy, HS; Mohamed, ME; Shehata, TM; Younis, NS | 1 |
| Huang, H; Luo, Y; Shi, J; Tan, Y; Yang, A; Ye, Y; Zhao, Y | 1 |
| Ida, H; Matsuda, K; Mihara, Y; Nakashima, M; Ohshima, K; Satake, K; Sugi, S; Sugiyama, G; Wakasugi, D; Yamaguchi, R; Yamasaki, S; Yoshida, N | 1 |
| Leung, N; Truong, H | 1 |
| Aga, AB; Breidenbach, J; Flåm, ST; Haavardsholm, EA; Heinicke, F; Leithaug, M; Lie, BA; Lillegraven, S; Mjaavatten, MD; Mæhlen, MT; Norli, ES; Rayner, S; Zhong, X; Zucknick, M | 1 |
| Chiarri Toumit, C; Hernandez Bel, L; Hernández Garfella, ML; Valenzuela Oñate, C | 1 |
| Amano, K; Higashi, M; Kimura, Y; Kizaki, M; Momose, S; Mori, T; Okamoto, S; Saito, S; Shimizu, T; Suzuki, K; Takeuchi, T; Tamaru, JI; Tokuhira, M | 1 |
| Alonso-Pacheco, ML; González-Ramos, J; Herranz-Pinto, P; Mayor-Ibarguren, A | 1 |
| Carrascosa, JM; de Lucas, R; Galán, M; Pérez-Ferriols, A; Ribera, M; Yanguas, I | 1 |
| Andersen, PK; Cortese, G; Nielsen, D; Nielsen, G; Ryberg, M; Skovsgaard, T | 1 |
| Di Rosa, R; Laganà, B; Luzi, G; Salemi, S | 1 |
| Lee, SL; Mouzakes, J; Neskey, D | 1 |
| Andritsos, L; Bechtel, T; Benson, DM; Blum, W; Byrd, JC; Devine, SM; Elder, P; Garzon, R; Hamadani, M; Hofmeister, C; Klisovic, R; Krugh, D; Lin, T; Marcucci, G; O'Donnell, L; Penza, S; Phillips, G | 1 |
| Aranda Torres, A; Blanco Pérez, JJ; Guerra Vales, JL; Núñez Delgado, M; Pego Reigosa, JM; Temes Montes, E | 1 |
| Castro Laria, L; Castro Márquez, C; Caunedo Álvarez, A; Cordero Ruiz, P; Herrerías Gutiérrez, JM; Méndez Rufián, V; Romero Vázquez, J | 1 |
| Blanco Alonso, R; Rueda Gotor, J | 1 |
| Aidi, S; Amarenco, P; El Amrani, M | 1 |
| Fleischmann, R; Iqbal, I; Stern, R | 1 |
| Dadlani, C; Orlow, SJ | 1 |
| Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA | 1 |
| Bruyn, GA; Houtman, PM; Mulder, J; Stenger, AA | 1 |
| Matherly, LH; Taub, JW | 1 |
| Herr, HW | 1 |
| Morrow, GR | 1 |
6 review(s) available for methotrexate and Diathesis
| Article | Year |
|---|---|
[Pulmonary tuberculosis associated to adalimumab: a study of 3 cases].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antitubercular Agents; Arthritis, Rheumatoid; Disease Susceptibility; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Opportunistic Infections; Spondylitis, Ankylosing; Tuberculosis, Miliary; Tuberculosis, Pulmonary; Tumor Necrosis Factor-alpha | 2010 |
[Tocilizumab in rheumatoid arthritis].
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Clinical Trials as Topic; Disease Susceptibility; Drug Therapy, Combination; Humans; Hypercholesterolemia; Infections; Methotrexate; Multicenter Studies as Topic; Receptors, Interleukin-6 | 2011 |
[Cerebral ischemic events and anti-cancer therapy].
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Brain Ischemia; Cerebral Hemorrhage; Child; Child, Preschool; Cisplatin; Disease Susceptibility; Female; Fluorouracil; Growth Inhibitors; Humans; Male; Methotrexate; Middle Aged; Neoplasms | 2003 |
Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Susceptibility; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infections; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Sialoglycoproteins; Treatment Outcome | 2004 |
Treatment of children and adolescents with methotrexate, cyclosporine, and etanercept: review of the dermatologic and rheumatologic literature.
Topics: Adolescent; Age Factors; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Disease Susceptibility; Etanercept; Female; Humans; Immunoglobulin G; Immunosuppressive Agents; Infections; Lymphoma; Male; Methotrexate; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Rheumatic Diseases; Skin Diseases | 2005 |
Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia.
Topics: Adult; Antimetabolites, Antineoplastic; Biological Transport; Biotransformation; Carrier Proteins; Child; Chromosomes, Human, Pair 21; Disease Susceptibility; Disease-Free Survival; Down Syndrome; Drug Resistance, Neoplasm; Folic Acid Antagonists; Half-Life; Humans; Membrane Proteins; Membrane Transport Proteins; Methotrexate; Neoplasm Proteins; Neoplastic Stem Cells; Polyglutamic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Reduced Folate Carrier Protein; Remission Induction; Tetrahydrofolate Dehydrogenase | 1996 |
3 trial(s) available for methotrexate and Diathesis
| Article | Year |
|---|---|
Are glucocorticoids a consistent risk factor for infections in rheumatoid arthritis patients under treatment with methotrexate and etanercept?
Topics: Adult; Aged; Aged, 80 and over; Arthritis, Rheumatoid; Bacterial Infections; Candidiasis, Vulvovaginal; Disease Susceptibility; Drug Therapy, Combination; Etanercept; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Otitis Media; Receptors, Tumor Necrosis Factor; Respiratory Tract Infections; Urinary Tract Infections | 2009 |
Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.
Topics: Adult; Aged; Animals; Anti-Infective Agents; Antilymphocyte Serum; Busulfan; Disease Susceptibility; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Infection Control; Infections; Male; Medical Audit; Methotrexate; Middle Aged; Myeloablative Agonists; Patient Isolation; Postoperative Complications; Rabbits; T-Lymphocytes; Tacrolimus; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2009 |
Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series.
Topics: Abdominal Abscess; Adalimumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; C-Reactive Protein; Crohn Disease; Disease Susceptibility; Drug Resistance; Drug Therapy, Combination; Female; Humans; Infliximab; Intestinal Fistula; Male; Methotrexate; Prednisone; Tuberculosis, Meningeal; Tumor Necrosis Factor-alpha | 2011 |
15 other study(ies) available for methotrexate and Diathesis
| Article | Year |
|---|---|
Geraniol Averts Methotrexate-Induced Acute Kidney Injury via Keap1/Nrf2/HO-1 and MAPK/NF-κB Pathways.
Topics: Acute Kidney Injury; Acyclic Monoterpenes; Animals; Apoptosis; Biomarkers; Biopsy; Disease Management; Disease Susceptibility; Heme Oxygenase (Decyclizing); Kelch-Like ECH-Associated Protein 1; Male; Methotrexate; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Protective Agents; Rats; Reactive Oxygen Species; Signal Transduction | 2021 |
Allo-HSCT recipients with invasive fungal disease and ongoing immunosuppression have a high risk for developing tuberculosis.
Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Disease Susceptibility; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Invasive Fungal Infections; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Prednisone; Risk; Transplant Recipients; Tuberculosis; Young Adult | 2019 |
A case of acute diffuse large B cell lymphoma in an anti-human T-cell leukaemia virus type 1-positive rheumatoid arthritis patient treated with methotrexate, who died.
Topics: Aged; Arthritis, Rheumatoid; Autopsy; Biomarkers; Disease Susceptibility; Fatal Outcome; Female; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Methotrexate | 2020 |
Fixed-Dose Glucarpidase for Toxic Methotrexate Levels and Acute Kidney Injury in Adult Lymphoma Patients: Case Series.
Topics: Acute Kidney Injury; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Disease Management; Disease Susceptibility; Female; gamma-Glutamyl Hydrolase; Humans; Kidney Function Tests; Lymphoma; Male; Methotrexate; Middle Aged; Recombinant Proteins; Treatment Outcome | 2021 |
MicroRNA Expression Differences in Blood-Derived CD19+ B Cells of Methotrexate Treated Rheumatoid Arthritis Patients.
Topics: Antigens, CD19; Arthritis, Rheumatoid; B-Lymphocytes; Biomarkers; Computational Biology; Disease Management; Disease Susceptibility; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; High-Throughput Nucleotide Sequencing; Humans; Immunosuppressive Agents; Methotrexate; MicroRNAs; RNA Interference | 2021 |
Anti-tumour necrosis factor-induced cutaneous leishmaniasis in patient with psoriatic arthritis and uveitis.
Topics: Adalimumab; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Disease Susceptibility; Drug Therapy, Combination; HLA-B27 Antigen; Humans; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Male; Methotrexate; Prednisone; Tumor Necrosis Factor-alpha; Uveitis, Anterior | 2018 |
Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Disease Susceptibility; Female; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Kaplan-Meier Estimate; Lymphoproliferative Disorders; Male; Methotrexate; Middle Aged; Tomography, X-Ray Computed | 2019 |
Gastric mucosa-associated lymphoid tissue lymphoma in a patient with severe psoriasis receiving ustekinumab.
Topics: Aged; Antirheumatic Agents; Disease Susceptibility; Humans; Immunocompromised Host; Immunosuppressive Agents; Lymphoma, B-Cell, Marginal Zone; Male; Methotrexate; Psoriasis; PUVA Therapy; Stomach Neoplasms; Ustekinumab | 2015 |
Expert Recommendations on Treating Psoriasis in Special Circumstances (Part II).
Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Biological Therapy; Child; Clinical Trials as Topic; Combined Modality Therapy; Delphi Technique; Disease Management; Disease Susceptibility; Etanercept; Humans; Immunosuppressive Agents; Infections; Methotrexate; Psoriasis; Quality of Life; Surveys and Questionnaires; Ultraviolet Therapy | 2016 |
New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
Topics: Adult; Age Factors; Aged; Anthracyclines; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Denmark; Disease Susceptibility; Drug Administration Schedule; Epirubicin; Female; Fluorouracil; Heart; Heart Failure; Humans; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Severity of Illness Index; Tamoxifen; Vindesine | 2008 |
Potential predisposition for nasal septal perforation with methotrexate use: report of 2 cases and literature review.
Topics: Antimetabolites, Antineoplastic; Antirheumatic Agents; Arthritis, Juvenile; Cartilage; Child; Disease Susceptibility; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nasal Septum; Nose Deformities, Acquired; Rhinoplasty | 2009 |
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha | 2006 |
Methotrexate may affect certain T lymphocyte subsets in rheumatoid arthritis resulting in susceptibility to Pneumocystis carinii infection.
Topics: Adult; Arthritis, Rheumatoid; Disease Susceptibility; Humans; Male; Methotrexate; Pneumocystis Infections; T-Lymphocyte Subsets | 1994 |
The natural history of a T1 bladder cancer: life-long tumour diathesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Susceptibility; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms; Vinblastine | 1999 |
The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Susceptibility; Epidemiologic Methods; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Motion Sickness; Nausea | 1985 |